Top Markets
Coin of the day
Sandoz Group AG Sandoz Group AG

Sandoz Group AG

SDZ
Rank in Stocks #622
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
Share Price
$95.44
Last synced: 2026-08-24
Market Cap
$41.29B
Change (1 day)
-0.62%
Change (1 year)
52.20%
Country
CH
Trade Sandoz Group AG (SDZ)

Category

Revenue for Sandoz Group AG (SDZ)
Revenue in Aug 2026 TTM: 0
According to Sandoz Group AG latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sandoz Group AG from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors